SCHEMBL18876545

SCHEMBL18876545

Cc1ccc(/C=N/NC(=O)c2cc3ccccc3cc2O)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.75
DNM1 Q05193 2/20 0.74
ECE2 P0DPD6 2/20 0.74
ECE1 P42892 2/20 0.74
MUS81 Q96NY9 2/20 0.74
MEN1 O00255 7/20 0.68
KMT2A Q03164 7/20 0.68
AR P10275 2/20 0.67
MGAM O43451 1/20 0.65
GAA P10253 1/20 0.65
SI P14410 1/20 0.65
MGAM2 Q2M2H8 1/20 0.65
NPC1 O15118 3/20 0.61
RAB9A P51151 3/20 0.61
SIRT1 Q96EB6 1/20 0.61
FTO Q9C0B1 1/20 0.61
SENP8 Q96LD8 1/20 0.60
SENP7 Q9BQF6 1/20 0.60
SENP6 Q9GZR1 1/20 0.60
PGR P06401 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17327760 0.89 L3MBTL1 (0.79) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL6635439 0.89 L3MBTL1 (0.82) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL5149469 0.89 L3MBTL1 (0.82) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL8925781 0.89 L3MBTL1 (0.82) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL25474226 0.87 DNM1 (0.79) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL18876543 0.87 DNM1 (0.79) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL12868832 0.87 DNM1 (0.71) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL13074793 0.87 DNM1 (0.79) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL17327816 0.87 L3MBTL1 (0.75) L3MBTL1DNM1ECE2ECE1MUS81
SCHEMBL14983909 0.86 DNM1 (0.82) L3MBTL1DNM1ECE2ECE1MUS81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170144965-A1 MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT THE UNIVERSITY OF KANSAS 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170144965-A1 MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT COIL, MUC1, MAN2B2 L3MBTL1 3214/4885DNM1 3453/4885ECE2 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.